369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts.
Publication
, Journal Article
Suryadevara, CM; Desai, R; Farber, SH; Gedeon, PC; Swartz, A; Snyder, D; Herndon, J; Healy, P; Choi, BD; Fecci, PE; Sanchez-Perez, L; Sampson, JH
Published in: Neurosurgery
August 1, 2016
Duke Scholars
Published In
Neurosurgery
DOI
EISSN
1524-4040
Publication Date
August 1, 2016
Volume
63
Issue
CN_suppl_1
Start / End Page
209 / 210
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Suryadevara, C. M., Desai, R., Farber, S. H., Gedeon, P. C., Swartz, A., Snyder, D., … Sampson, J. H. (2016). 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery, 63(CN_suppl_1), 209–210. https://doi.org/10.1227/01.neu.0000489857.70440.98
Suryadevara, C. M., R. Desai, S. H. Farber, P. C. Gedeon, A. Swartz, D. Snyder, J. Herndon, et al. “369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts.” Neurosurgery 63, no. CN_suppl_1 (August 1, 2016): 209–10. https://doi.org/10.1227/01.neu.0000489857.70440.98.
Suryadevara CM, Desai R, Farber SH, Gedeon PC, Swartz A, Snyder D, et al. 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery. 2016 Aug 1;63(CN_suppl_1):209–10.
Suryadevara, C. M., et al. “369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts.” Neurosurgery, vol. 63, no. CN_suppl_1, Aug. 2016, pp. 209–10. Pubmed, doi:10.1227/01.neu.0000489857.70440.98.
Suryadevara CM, Desai R, Farber SH, Gedeon PC, Swartz A, Snyder D, Herndon J, Healy P, Choi BD, Fecci PE, Sanchez-Perez L, Sampson JH. 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery. 2016 Aug 1;63(CN_suppl_1):209–210.
Published In
Neurosurgery
DOI
EISSN
1524-4040
Publication Date
August 1, 2016
Volume
63
Issue
CN_suppl_1
Start / End Page
209 / 210
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences